U.S. Home Infusion Therapy Market By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others ), By Region (East North Central {Illinois, Indiana, Michigan, Ohio, Wisconsin}, West South Central {Arkansas, Louisiana, Oklahoma, Texas},South Atlantic {Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Washington, D.C}, North East {Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania}, East South Central {Alabama, Kentucky, Mississippi, Tennessee}, West North Central {Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota}, Pacific Central {Alaska, California, Hawaii, Oregon, Washington}, Mountain States {Arizona, Colorado, Utah, Nevada, New Mexico, Idaho, Montana, Wyoming}) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-212 | Category : Healthcare | Published Date : May, 2019 | Pages : 402 | Format :PDF
Buy Now!

Industry Trends

U.S. home infusion therapy market was valued at US$ 7,849.6 million in 2018 and is estimated to reach US$ 19,250.0 million by 2027, growing at a CAGR of 10.5% over the forecast period.

U.S. Home Infusion Therapy Market Revenue, 2019 - 2027

Increasing technological advancements with regards to automations in healthcare devices are fueling U.S. home infusion therapy market growth. Advancement such as modification of conventional insulin infusion pumps into smart ones with reduced dosage error and easy usage are prominent driving factors of market growth. Moreover, from the demand side, rapidly expanding geriatric patient pool happens to be the primary reason behind growing adoption of various home infusion therapy products across the U.S. Government funding in research and development to provide best possible solutions to the elderly is further promoting market expansion.

Rising incidences of chronic diseases such as diabetes, respiratory disorders, cancer, and so on, are augmenting demand for home infusion therapies. The need to provide continuous monitoring and therapy to patients with chronic diseases will spur demand for home care devices during the forecast timeframe.

High average household income and access to healthcare are other major market growth promoting factors in some of the regions across the U.S. Increasing affordability of various devices due to insurance provision will drive U.S. home infusion therapy market in certain regions.

However, reimbursement limitation proves to be a major hurdle in market expansion path. Lack of reimbursement and insurance on some of the devices hinder their adoption, and thus market growth. Furthermore, sporadic affordability across the nations restrains market expansion.

Infusion pumps, intravenous sets, IV cannulas and needleless connectors are some of the major products used in home therapy. Infusion pumps held the largest market share in 2018 and it is estimated to expand at a rapid rate over the projection period. Infusion pumps market growth is attributed to effectiveness and easy usage offered by modern pumps.

Anti-infective home infusion therapy accounted for the largest market share in 2018, owing to the high rate of hospital acquired infections. Over the forecast period, parenteral home infusion therapy will be largely responsible for driving market growth. Increasing incidences of gastro-intestinal tract disorders which require continuous parenteral infusion of food and medicine, will augment market expansion.

South Atlantic region home infusion therapy market, held largest market share and is estimated to hold its dominance in future years. High average household income and access to healthcare are the major reasons behind rising demand for home infusion products across the region.  

Pacific central region home infusion market is anticipated to grow rapidly owing to increasing government efforts to offer affordable home care solutions to geriatric population across the region.

The report provides both, qualitative and quantitative research of U.S. home infusion therapy market, it also provides penetrative insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in the market and detailed insights into the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by major players are also recognized and analyzed in the report. For each company, the report recognizes its headquarter, competitors, product/service type, application and specification, pricing, and gross margin.

Competitive Landscape

Major industry participants in U.S. home infusion therapy market include Baxter International, Becton Dickinson, Fresenius Kabi, Smith Medical, B. Braun, Amsino International, Halyard Health and Terumo Corporation among others. New product launches, merger and acquisition, geographical expansion are some of the major strategies adopted by these players to gain a competitive edge.


U.S. Home Infusion Therapy Market :

  • By Product
    • Infusion pumps
    • Intravenous sets
    • IV cannulas
    • Needleless connectors
  • By Application
    • Anti-infectives
    • Hydration therapy
    • Chemotherapy
    • Enteral nutrition
    • Parenteral nutrition
    • Specialty pharmaceuticals
    • Others
  • By Geography
    • East North Central
      • Illinois
      • Indiana
      • Michigan
      • Ohio
      • Wisconsin
    • West South Central
      • Arkansas
      • Louisiana
      • Oklahoma
      • Texas
    • South Atlantic
      • Delaware
      • Georgia
      • Maryland
      • North Carolina
      • South Carolina
      • Virginia
      • West Virginia
      • Washington D.C.
    • North East
      • Connecticut
      • Maine
      • Massachusetts
      • New Hampshire
      • Rhode Islands
      • Vermont
      • New Jersey
      • New York
      • Pennsylvania
    • East South Central
      • Alabama
      • Kentucky
      • Mississippi
      • Tennessee
    • West North Central
      • Iowa
      • Kansas
      • Minnesota
      • Missouri
      • Nebraska
      • North Dakota
      • South Dakota
    • Pacific Central
      • Alaska
      • California
      • Hawaii
      • Oregon
      • Washington
    • Mountain States
      • Arizona
      • Colorado
      • Utah
      • Nevada
      • New Mexico
      • Idaho
      • Montana
      • Wyoming

Key Questions

Request Sample

Report Customization

Request for Customization

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2017

1.2.2. Base Year: 2018

1.2.3. Forecast Years: 2019 – 2027

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. U.S. Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of United States Home Infusion Therapy Market

6.    Market Synopsis:  United States Home Infusion Therapy Market

7.    United States Home Infusion Therapy Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in Home Infusion Therapy Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Home Infusion Therapy Market

7.6. Industry Gross Margin Overview

7.7. Porter’s Five Force Analysis

7.8. PESTEL Analysis

8.    U.S. Home Infusion Therapy Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. U.S. Home Infusion Therapy Market Revenue (US$ Mn)

8.2. U.S. Home Infusion Therapy Market Revenue (US$ Mn) and  Forecasts, By Product

8.2.1. Infusion pumps

8.2.1.1. Definition

8.2.1.2. Market Penetration, 2018

8.2.1.3. Market Estimation, 2015 – 2018

8.2.1.4. Market Forecast, 2019 – 2027

8.2.1.5. Compound Annual Growth Rate (CAGR)

8.2.1.6. Regional Bifurcation

8.2.1.6.1.    East North Central

8.2.1.6.1.1. Market Estimation, 2015 – 2018

8.2.1.6.1.2. Market Forecast, 2019 – 2027

8.2.1.6.2.    West South Central

8.2.1.6.2.1. Market Estimation, 2015 – 2018

8.2.1.6.2.2. Market Forecast, 2019 – 2027

8.2.1.6.3.    South Atlantic

8.2.1.6.3.1. Market Estimation, 2015 – 2018

8.2.1.6.3.2. Market Forecast, 2019 – 2027

8.2.1.6.4.    North East

8.2.1.6.4.1. Market Estimation, 2015 – 2018

8.2.1.6.4.2. Market Forecast, 2019 – 2027

8.2.1.6.5.    East South Central

8.2.1.6.5.1. Market Estimation, 2015 – 2018

8.2.1.6.5.2. Market Forecast, 2019 – 2027

8.2.1.6.6.    West North Central

8.2.1.6.6.1. Market Estimation, 2015 – 2018

8.2.1.6.6.2. Market Forecast, 2019 – 2027

8.2.1.6.7.    Pacific Central

8.2.1.6.7.1. Market Estimation, 2015 – 2018

8.2.1.6.7.2. Market Forecast, 2019 – 2027

8.2.1.6.8.    Mountain States

8.2.1.6.8.1. Market Estimation, 2015 – 2018

8.2.1.6.8.2. Market Forecast, 2019 – 2027

8.2.2. Intravenous sets

8.2.2.1. Definition

8.2.2.2. Market Penetration, 2018

8.2.2.3. Market Estimation, 2015 – 2018

8.2.2.4. Market Forecast, 2019 – 2027

8.2.2.5. Compound Annual Growth Rate (CAGR)

8.2.2.6. Regional Bifurcation

8.2.2.6.1.    East North Central

8.2.2.6.1.1. Market Estimation, 2015 – 2018

8.2.2.6.1.2. Market Forecast, 2019 – 2027

8.2.2.6.2.    West South Central

8.2.2.6.2.1. Market Estimation, 2015 – 2018

8.2.2.6.2.2. Market Forecast, 2019 – 2027

8.2.2.6.3.    South Atlantic

8.2.2.6.3.1. Market Estimation, 2015 – 2018

8.2.2.6.3.2. Market Forecast, 2019 – 2027

8.2.2.6.4.    North East

8.2.2.6.4.1. Market Estimation, 2015 – 2018

8.2.2.6.4.2. Market Forecast, 2019 – 2027

8.2.2.6.5.    East South Central

8.2.2.6.5.1. Market Estimation, 2015 – 2018

8.2.2.6.5.2. Market Forecast, 2019 – 2027

8.2.2.6.6.    West North Central

8.2.2.6.6.1. Market Estimation, 2015 – 2018

8.2.2.6.6.2. Market Forecast, 2019 – 2027

8.2.2.6.7.    Pacific Central

8.2.2.6.7.1. Market Estimation, 2015 – 2018

8.2.2.6.7.2. Market Forecast, 2019 – 2027

8.2.2.6.8.    Mountain States

8.2.2.6.8.1. Market Estimation, 2015 – 2018

8.2.2.6.8.2. Market Forecast, 2019 – 2027

8.2.3. IV cannulas

8.2.3.1. Definition

8.2.3.2. Market Penetration, 2018

8.2.3.3. Market Estimation, 2015 – 2018

8.2.3.4. Market Forecast, 2019 – 2027

8.2.3.5. Compound Annual Growth Rate (CAGR)

8.2.3.6. Regional Bifurcation

8.2.3.6.1.    East North Central

8.2.3.6.1.1. Market Estimation, 2015 – 2018

8.2.3.6.1.2. Market Forecast, 2019 – 2027

8.2.3.6.2.    West South Central

8.2.3.6.2.1. Market Estimation, 2015 – 2018

8.2.3.6.2.2. Market Forecast, 2019 – 2027

8.2.3.6.3.    South Atlantic

8.2.3.6.3.1. Market Estimation, 2015 – 2018

8.2.3.6.3.2. Market Forecast, 2019 – 2027

8.2.3.6.4.    North East

8.2.3.6.4.1. Market Estimation, 2015 – 2018

8.2.3.6.4.2. Market Forecast, 2019 – 2027

8.2.3.6.5.    East South Central

8.2.3.6.5.1. Market Estimation, 2015 – 2018

8.2.3.6.5.2. Market Forecast, 2019 – 2027

8.2.3.6.6.    West North Central

8.2.3.6.6.1. Market Estimation, 2015 – 2018

8.2.3.6.6.2. Market Forecast, 2019 – 2027

8.2.3.6.7.    Pacific Central

8.2.3.6.7.1. Market Estimation, 2015 – 2018

8.2.3.6.7.2. Market Forecast, 2019 – 2027

8.2.3.6.8.    Mountain States

8.2.3.6.8.1. Market Estimation, 2015 – 2018

8.2.3.6.8.2. Market Forecast, 2019 – 2027

8.2.4. Needleless connectors

8.2.4.1. Definition

8.2.4.2. Market Penetration, 2018

8.2.4.3. Market Estimation, 2015 – 2018

8.2.4.4. Market Forecast, 2019 – 2027

8.2.4.5. Compound Annual Growth Rate (CAGR)

8.2.4.6. Regional Bifurcation

8.2.4.6.1.    East North Central

8.2.4.6.1.1. Market Estimation, 2015 – 2018

8.2.4.6.1.2. Market Forecast, 2019 – 2027

8.2.4.6.2.    West South Central

8.2.4.6.2.1. Market Estimation, 2015 – 2018

8.2.4.6.2.2. Market Forecast, 2019 – 2027

8.2.4.6.3.    South Atlantic

8.2.4.6.3.1. Market Estimation, 2015 – 2018

8.2.4.6.3.2. Market Forecast, 2019 – 2027

8.2.4.6.4.    North East

8.2.4.6.4.1. Market Estimation, 2015 – 2018

8.2.4.6.4.2. Market Forecast, 2019 – 2027

8.2.4.6.5.    East South Central

8.2.4.6.5.1. Market Estimation, 2015 – 2018

8.2.4.6.5.2. Market Forecast, 2019 – 2027

8.2.4.6.6.    West North Central

8.2.4.6.6.1. Market Estimation, 2015 – 2018

8.2.4.6.6.2. Market Forecast, 2019 – 2027

8.2.4.6.7.    Pacific Central

8.2.4.6.7.1. Market Estimation, 2015 – 2018

8.2.4.6.7.2. Market Forecast, 2019 – 2027

8.2.4.6.8.    Mountain States

8.2.4.6.8.1. Market Estimation, 2015 – 2018

8.2.4.6.8.2. Market Forecast, 2019 – 2027

8.2.5. Others

8.2.5.1. Definition

8.2.5.2. Market Penetration, 2018

8.2.5.3. Market Estimation, 2015 – 2018

8.2.5.4. Market Forecast, 2019 – 2027

8.2.5.5. Compound Annual Growth Rate (CAGR)

8.2.5.6. Regional Bifurcation

8.2.5.6.1.    East North Central

8.2.5.6.1.1. Market Estimation, 2015 – 2018

8.2.5.6.1.2. Market Forecast, 2019 – 2027

8.2.5.6.2.    West South Central

8.2.5.6.2.1. Market Estimation, 2015 – 2018

8.2.5.6.2.2. Market Forecast, 2019 – 2027

8.2.5.6.3.    South Atlantic

8.2.5.6.3.1. Market Estimation, 2015 – 2018

8.2.5.6.3.2. Market Forecast, 2019 – 2027

8.2.5.6.4.    North East

8.2.5.6.4.1. Market Estimation, 2015 – 2018

8.2.5.6.4.2. Market Forecast, 2019 – 2027

8.2.5.6.5.    East South Central

8.2.5.6.5.1. Market Estimation, 2015 – 2018

8.2.5.6.5.2. Market Forecast, 2019 – 2027

8.2.5.6.6.    West North Central

8.2.5.6.6.1. Market Estimation, 2015 – 2018

8.2.5.6.6.2. Market Forecast, 2019 – 2027

8.2.5.6.7.    Pacific Central

8.2.5.6.7.1. Market Estimation, 2015 – 2018

8.2.5.6.7.2. Market Forecast, 2019 – 2027

8.2.5.6.8.    Mountain States

8.2.5.6.8.1. Market Estimation, 2015 – 2018

8.2.5.6.8.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Product

9.    U.S. Home Infusion Therapy Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. U.S. Home Infusion Therapy Market Revenue (US$ Mn) and  Forecasts, By Application

9.2.1. Anti-infectives

9.2.1.1. Definition

9.2.1.2. Market Penetration, 2018

9.2.1.3. Market Estimation, 2015 – 2018

9.2.1.4. Market Forecast, 2019 – 2027

9.2.1.5. Compound Annual Growth Rate (CAGR)

9.2.1.6. Regional Bifurcation

9.2.1.6.1.    East North Central

9.2.1.6.1.1. Market Estimation, 2015 – 2018

9.2.1.6.1.2. Market Forecast, 2019 – 2027

9.2.1.6.2.    West South Central

9.2.1.6.2.1. Market Estimation, 2015 – 2018

9.2.1.6.2.2. Market Forecast, 2019 – 2027

9.2.1.6.3.    South Atlantic

9.2.1.6.3.1. Market Estimation, 2015 – 2018

9.2.1.6.3.2. Market Forecast, 2019 – 2027

9.2.1.6.4.    North East

9.2.1.6.4.1. Market Estimation, 2015 – 2018

9.2.1.6.4.2. Market Forecast, 2019 – 2027

9.2.1.6.5.    East South Central

9.2.1.6.5.1. Market Estimation, 2015 – 2018

9.2.1.6.5.2. Market Forecast, 2019 – 2027

9.2.1.6.6.    West North Central

9.2.1.6.6.1. Market Estimation, 2015 – 2018

9.2.1.6.6.2. Market Forecast, 2019 – 2027

9.2.1.6.7.    Pacific Central

9.2.1.6.7.1. Market Estimation, 2015 – 2018

9.2.1.6.7.2. Market Forecast, 2019 – 2027

9.2.1.6.8.    Mountain States

9.2.1.6.8.1. Market Estimation, 2015 – 2018

9.2.1.6.8.2. Market Forecast, 2019 – 2027

9.2.2. Hydration therapy

9.2.2.1. Definition

9.2.2.2. Market Penetration, 2018

9.2.2.3. Market Estimation, 2015 – 2018

9.2.2.4. Market Forecast, 2019 – 2027

9.2.2.5. Compound Annual Growth Rate (CAGR)

9.2.2.6. Regional Bifurcation

9.2.2.6.1.    East North Central

9.2.2.6.1.1. Market Estimation, 2015 – 2018

9.2.2.6.1.2. Market Forecast, 2019 – 2027

9.2.2.6.2.    West South Central

9.2.2.6.2.1. Market Estimation, 2015 – 2018

9.2.2.6.2.2. Market Forecast, 2019 – 2027

9.2.2.6.3.    South Atlantic

9.2.2.6.3.1. Market Estimation, 2015 – 2018

9.2.2.6.3.2. Market Forecast, 2019 – 2027

9.2.2.6.4.    North East

9.2.2.6.4.1. Market Estimation, 2015 – 2018

9.2.2.6.4.2. Market Forecast, 2019 – 2027

9.2.2.6.5.    East South Central

9.2.2.6.5.1. Market Estimation, 2015 – 2018

9.2.2.6.5.2. Market Forecast, 2019 – 2027

9.2.2.6.6.    West North Central

9.2.2.6.6.1. Market Estimation, 2015 – 2018

9.2.2.6.6.2. Market Forecast, 2019 – 2027

9.2.2.6.7.    Pacific Central

9.2.2.6.7.1. Market Estimation, 2015 – 2018

9.2.2.6.7.2. Market Forecast, 2019 – 2027

9.2.2.6.8.    Mountain States

9.2.2.6.8.1. Market Estimation, 2015 – 2018

9.2.2.6.8.2. Market Forecast, 2019 – 2027

9.2.3. Chemotherapy

9.2.3.1. Definition

9.2.3.2. Market Penetration, 2018

9.2.3.3. Market Estimation, 2015 – 2018

9.2.3.4. Market Forecast, 2019 – 2027

9.2.3.5. Compound Annual Growth Rate (CAGR)

9.2.3.6. Regional Bifurcation

9.2.3.6.1.    East North Central

9.2.3.6.1.1. Market Estimation, 2015 – 2018

9.2.3.6.1.2. Market Forecast, 2019 – 2027

9.2.3.6.2.    West South Central

9.2.3.6.2.1. Market Estimation, 2015 – 2018

9.2.3.6.2.2. Market Forecast, 2019 – 2027

9.2.3.6.3.    South Atlantic

9.2.3.6.3.1. Market Estimation, 2015 – 2018

9.2.3.6.3.2. Market Forecast, 2019 – 2027

9.2.3.6.4.    North East

9.2.3.6.4.1. Market Estimation, 2015 – 2018

9.2.3.6.4.2. Market Forecast, 2019 – 2027

9.2.3.6.5.    East South Central

9.2.3.6.5.1. Market Estimation, 2015 – 2018

9.2.3.6.5.2. Market Forecast, 2019 – 2027

9.2.3.6.6.    West North Central

9.2.3.6.6.1. Market Estimation, 2015 – 2018

9.2.3.6.6.2. Market Forecast, 2019 – 2027

9.2.3.6.7.    Pacific Central

9.2.3.6.7.1. Market Estimation, 2015 – 2018

9.2.3.6.7.2. Market Forecast, 2019 – 2027

9.2.3.6.8.    Mountain States

9.2.3.6.8.1. Market Estimation, 2015 – 2018

9.2.3.6.8.2. Market Forecast, 2019 – 2027

9.2.4. Enteral nutrition

9.2.4.1. Definition

9.2.4.2. Market Penetration, 2018

9.2.4.3. Market Estimation, 2015 – 2018

9.2.4.4. Market Forecast, 2019 – 2027

9.2.4.5. Compound Annual Growth Rate (CAGR)

9.2.4.6. Regional Bifurcation

9.2.4.6.1.    East North Central

9.2.4.6.1.1. Market Estimation, 2015 – 2018

9.2.4.6.1.2. Market Forecast, 2019 – 2027

9.2.4.6.2.    West South Central

9.2.4.6.2.1. Market Estimation, 2015 – 2018

9.2.4.6.2.2. Market Forecast, 2019 – 2027

9.2.4.6.3.    South Atlantic

9.2.4.6.3.1. Market Estimation, 2015 – 2018

9.2.4.6.3.2. Market Forecast, 2019 – 2027

9.2.4.6.4.    North East

9.2.4.6.4.1. Market Estimation, 2015 – 2018

9.2.4.6.4.2. Market Forecast, 2019 – 2027

9.2.4.6.5.    East South Central

9.2.4.6.5.1. Market Estimation, 2015 – 2018

9.2.4.6.5.2. Market Forecast, 2019 – 2027

9.2.4.6.6.    West North Central

9.2.4.6.6.1. Market Estimation, 2015 – 2018

9.2.4.6.6.2. Market Forecast, 2019 – 2027

9.2.4.6.7.    Pacific Central

9.2.4.6.7.1. Market Estimation, 2015 – 2018

9.2.4.6.7.2. Market Forecast, 2019 – 2027

9.2.4.6.8.    Mountain States

9.2.4.6.8.1. Market Estimation, 2015 – 2018

9.2.4.6.8.2. Market Forecast, 2019 – 2027

9.2.5. Parenteral nutrition

9.2.5.1. Definition

9.2.5.2. Market Penetration, 2018

9.2.5.3. Market Estimation, 2015 – 2018

9.2.5.4. Market Forecast, 2019 – 2027

9.2.5.5. Compound Annual Growth Rate (CAGR)

9.2.5.6. Regional Bifurcation

9.2.5.6.1.    East North Central

9.2.5.6.1.1. Market Estimation, 2015 – 2018

9.2.5.6.1.2. Market Forecast, 2019 – 2027

9.2.5.6.2.    West South Central

9.2.5.6.2.1. Market Estimation, 2015 – 2018

9.2.5.6.2.2. Market Forecast, 2019 – 2027

9.2.5.6.3.    South Atlantic

9.2.5.6.3.1. Market Estimation, 2015 – 2018

9.2.5.6.3.2. Market Forecast, 2019 – 2027

9.2.5.6.4.    North East

9.2.5.6.4.1. Market Estimation, 2015 – 2018

9.2.5.6.4.2. Market Forecast, 2019 – 2027

9.2.5.6.5.    East South Central

9.2.5.6.5.1. Market Estimation, 2015 – 2018

9.2.5.6.5.2. Market Forecast, 2019 – 2027

9.2.5.6.6.    West North Central

9.2.5.6.6.1. Market Estimation, 2015 – 2018

9.2.5.6.6.2. Market Forecast, 2019 – 2027

9.2.5.6.7.    Pacific Central

9.2.5.6.7.1. Market Estimation, 2015 – 2018

9.2.5.6.7.2. Market Forecast, 2019 – 2027

9.2.5.6.8.    Mountain States

9.2.5.6.8.1. Market Estimation, 2015 – 2018

9.2.5.6.8.2. Market Forecast, 2019 – 2027

9.2.6. Specialty pharmaceuticals

9.2.6.1. Definition

9.2.6.2. Market Penetration, 2018

9.2.6.3. Market Estimation, 2015 – 2018

9.2.6.4. Market Forecast, 2019 – 2027

9.2.6.5. Compound Annual Growth Rate (CAGR)

9.2.6.6. Regional Bifurcation

9.2.6.6.1.    East North Central

9.2.6.6.1.1. Market Estimation, 2015 – 2018

9.2.6.6.1.2. Market Forecast, 2019 – 2027

9.2.6.6.2.    West South Central

9.2.6.6.2.1. Market Estimation, 2015 – 2018

9.2.6.6.2.2. Market Forecast, 2019 – 2027

9.2.6.6.3.    South Atlantic

9.2.6.6.3.1. Market Estimation, 2015 – 2018

9.2.6.6.3.2. Market Forecast, 2019 – 2027

9.2.6.6.4.    North East

9.2.6.6.4.1. Market Estimation, 2015 – 2018

9.2.6.6.4.2. Market Forecast, 2019 – 2027

9.2.6.6.5.    East South Central

9.2.6.6.5.1. Market Estimation, 2015 – 2018

9.2.6.6.5.2. Market Forecast, 2019 – 2027

9.2.6.6.6.    West North Central

9.2.6.6.6.1. Market Estimation, 2015 – 2018

9.2.6.6.6.2. Market Forecast, 2019 – 2027

9.2.6.6.7.    Pacific Central

9.2.6.6.7.1. Market Estimation, 2015 – 2018

9.2.6.6.7.2. Market Forecast, 2019 – 2027

9.2.6.6.8.    Mountain States

9.2.6.6.8.1. Market Estimation, 2015 – 2018

9.2.6.6.8.2. Market Forecast, 2019 – 2027

9.2.7. Other application

9.2.7.1. Definition

9.2.7.2. Market Penetration, 2018

9.2.7.3. Market Estimation, 2015 – 2018

9.2.7.4. Market Forecast, 2019 – 2027

9.2.7.5. Compound Annual Growth Rate (CAGR)

9.2.7.6. Regional Bifurcation

9.2.7.6.1.    East North Central

9.2.7.6.1.1. Market Estimation, 2015 – 2018

9.2.7.6.1.2. Market Forecast, 2019 – 2027

9.2.7.6.2.    West South Central

9.2.7.6.2.1. Market Estimation, 2015 – 2018

9.2.7.6.2.2. Market Forecast, 2019 – 2027

9.2.7.6.3.    South Atlantic

9.2.7.6.3.1. Market Estimation, 2015 – 2018

9.2.7.6.3.2. Market Forecast, 2019 – 2027

9.2.7.6.4.    North East

9.2.7.6.4.1. Market Estimation, 2015 – 2018

9.2.7.6.4.2. Market Forecast, 2019 – 2027

9.2.7.6.5.    East South Central

9.2.7.6.5.1. Market Estimation, 2015 – 2018

9.2.7.6.5.2. Market Forecast, 2019 – 2027

9.2.7.6.6.    West North Central

9.2.7.6.6.1. Market Estimation, 2015 – 2018

9.2.7.6.6.2. Market Forecast, 2019 – 2027

9.2.7.6.7.    Pacific Central

9.2.7.6.7.1. Market Estimation, 2015 – 2018

9.2.7.6.7.2. Market Forecast, 2019 – 2027

9.2.7.6.8.    Mountain States

9.2.7.6.8.1. Market Estimation, 2015 – 2018

9.2.7.6.8.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By Application

10. U.S. Home Infusion Therapy Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. U.S. Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts By Zones

10.2.1. East North Central

10.2.1.1. East North Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Product

10.2.1.1.1.  Infusion pumps

10.2.1.1.2.  Intravenous sets

10.2.1.1.3.  IV cannulas

10.2.1.1.4.  Needleless connectors

10.2.1.1.5.  Others

10.2.1.2. East North Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.1.2.1.  Anti-infectives

10.2.1.2.2.  Hydration therapy

10.2.1.2.3.  Chemotherapy

10.2.1.2.4.  Enteral nutrition

10.2.1.2.5.  Parenteral nutrition

10.2.1.2.6.  Specialty pharmaceuticals

10.2.1.2.7.  Other application

10.2.1.3. East North Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By State

10.2.1.3.1.  Illinois

10.2.1.3.2.  Indiana

10.2.1.3.3.  Michigan

10.2.1.3.4.  Ohio

10.2.1.3.5.  Wisconsin

10.2.2. West South Central

10.2.2.1. West South Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Product

10.2.2.1.1.  Infusion pumps

10.2.2.1.2.  Intravenous sets

10.2.2.1.3.  IV cannulas

10.2.2.1.4.  Needleless connectors

10.2.2.1.5.  Others

10.2.2.2. West South Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.2.2.1.  Anti-infectives

10.2.2.2.2.  Hydration therapy

10.2.2.2.3.  Chemotherapy

10.2.2.2.4.  Enteral nutrition

10.2.2.2.5.  Parenteral nutrition

10.2.2.2.6.  Specialty pharmaceuticals

10.2.2.2.7.  Other application

10.2.2.3. West South Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By State

10.2.2.3.1.  Arkansas

10.2.2.3.2.  Louisiana

10.2.2.3.3.  Oklahoma

10.2.2.3.4.  Texas

10.2.3. South Atlantic

10.2.3.1. South Atlantic Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Product

10.2.3.1.1.  Infusion pumps

10.2.3.1.2.  Intravenous sets

10.2.3.1.3.  IV cannulas

10.2.3.1.4.  Needleless connectors

10.2.3.1.5.  Others

10.2.3.2. South Atlantic Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.3.2.1.  Anti-infectives

10.2.3.2.2.  Hydration therapy

10.2.3.2.3.  Chemotherapy

10.2.3.2.4.  Enteral nutrition

10.2.3.2.5.  Parenteral nutrition

10.2.3.2.6.  Specialty pharmaceuticals

10.2.3.2.7.  Other application

10.2.3.3. South Atlantic Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By States

10.2.3.3.1.  Delaware

10.2.3.3.2.  Georgia

10.2.3.3.3.  Maryland

10.2.3.3.4.  North Carolina

10.2.3.3.5.  South Carolina

10.2.3.3.6.  Virginia

10.2.3.3.7.  West Virginia

10.2.3.3.8.  Washington D.C.

10.2.4. North East

10.2.4.1. North East Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Product

10.2.4.1.1.  Infusion pumps

10.2.4.1.2.  Intravenous sets

10.2.4.1.3.  IV cannulas

10.2.4.1.4.  Needleless connectors

10.2.4.1.5.  Others

10.2.4.2. North East Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.4.2.1.  Anti-infectives

10.2.4.2.2.  Hydration therapy

10.2.4.2.3.  Chemotherapy

10.2.4.2.4.  Enteral nutrition

10.2.4.2.5.  Parenteral nutrition

10.2.4.2.6.  Specialty pharmaceuticals

10.2.4.2.7.  Other application

10.2.4.3. North East Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By States

10.2.4.3.1.  Connecticut

10.2.4.3.2.  Maine

10.2.4.3.3.  Massachusetts

10.2.4.3.4.  New Hampshire

10.2.4.3.5.  Rhode Islands

10.2.4.3.6.  Vermont

10.2.4.3.7.  New Jersey

10.2.4.3.8.  New York

10.2.4.3.9.  Pennsylvania

10.2.5. East South Central

10.2.5.1. East South-Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Product

10.2.5.1.1.  Infusion pumps

10.2.5.1.2.  Intravenous sets

10.2.5.1.3.  IV cannulas

10.2.5.1.4.  Needleless connectors

10.2.5.1.5.  Others

10.2.5.2. East South Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.5.2.1.  Anti-infectives

10.2.5.2.2.  Hydration therapy

10.2.5.2.3.  Chemotherapy

10.2.5.2.4.  Enteral nutrition

10.2.5.2.5.  Parenteral nutrition

10.2.5.2.6.  Specialty pharmaceuticals

10.2.5.2.7.  Other application

10.2.5.3. East South Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By States

10.2.5.3.1.  Alabama

10.2.5.3.2.  Kentucky

10.2.5.3.3.  Mississippi

10.2.5.3.4.  Tennessee

10.2.6. West North Central

10.2.6.1. West North Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Product

10.2.6.1.1.  Infusion pumps

10.2.6.1.2.  Intravenous sets

10.2.6.1.3.  IV cannulas

10.2.6.1.4.  Needleless connectors

10.2.6.1.5.  Others

10.2.6.2. West North Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.6.2.1.  Anti-infectives

10.2.6.2.2.  Hydration therapy

10.2.6.2.3.  Chemotherapy

10.2.6.2.4.  Enteral nutrition

10.2.6.2.5.  Parenteral nutrition

10.2.6.2.6.  Specialty pharmaceuticals

10.2.6.2.7.  Other application

10.2.6.3. West North Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.6.3.1.  Iowa

10.2.6.3.2.  Kansas

10.2.6.3.3.  Minnesota

10.2.6.3.4.  Missouri

10.2.6.3.5.  Nebraska

10.2.6.3.6.  North Dakota

10.2.6.3.7.  South Dakota

10.2.7. Pacific Central

10.2.7.1. Pacific Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Product

10.2.7.1.1.  Infusion pumps

10.2.7.1.2.  Intravenous sets

10.2.7.1.3.  IV cannulas

10.2.7.1.4.  Needleless connectors

10.2.7.1.5.  Others

10.2.7.2. Pacific Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.7.2.1.  Anti-infectives

10.2.7.2.2.  Hydration therapy

10.2.7.2.3.  Chemotherapy

10.2.7.2.4.  Enteral nutrition

10.2.7.2.5.  Parenteral nutrition

10.2.7.2.6.  Specialty pharmaceuticals

10.2.7.2.7.  Other application

10.2.7.3. Pacific Central Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By States

10.2.7.3.1.  Alaska

10.2.7.3.2.  California

10.2.7.3.3.  Hawaii

10.2.7.3.4.  Oregon

10.2.7.3.5.  Washington

10.2.8. Mountain States

10.2.8.1. Mountain States Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Product

10.2.8.1.1.  Infusion pumps

10.2.8.1.2.  Intravenous sets

10.2.8.1.3.  IV cannulas

10.2.8.1.4.  Needleless connectors

10.2.8.1.5.  Others

10.2.8.2. Mountain States Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By Application

10.2.8.2.1.  Anti-infectives

10.2.8.2.2.  Hydration therapy

10.2.8.2.3.  Chemotherapy

10.2.8.2.4.  Enteral nutrition

10.2.8.2.5.  Parenteral nutrition

10.2.8.2.6.  Specialty pharmaceuticals

10.2.8.2.7.  Other application

10.2.8.3. Mountain States Home Infusion Therapy Market Revenue (US$ Mn) and Forecasts, By States

10.2.8.3.1.  Arizona

10.2.8.3.2.  Colorado

10.2.8.3.3.  Utah

10.2.8.3.4.  Nevada

10.2.8.3.5.  New Mexico

10.2.8.3.6.  Idaho

10.2.8.3.7.  Montana

10.2.8.3.8.  Wyoming

11. Competitive Benchmarking

11.1. Brand Benchmarking

11.2. Market Share Analysis, 2018

11.3. U.S. Presence and Growth Strategies

11.3.1. Mergers and Acquisitions

11.3.2. Product Launches

11.3.3. Investments Trends

11.3.4. R&D Initiatives

12. Player Profiles

12.1. Baxter International

12.1.1. Company Details

12.1.2. Company Overview

12.1.3. Product Offerings

12.1.4. Key Developments

12.1.5. Financial Analysis

12.1.6. SWOT Analysis

12.1.7. Business Strategies

12.2. Becton Dickinson

12.2.1. Company Details

12.2.2. Company Overview

12.2.3. Product Offerings

12.2.4. Key Developments

12.2.5. Financial Analysis

12.2.6. SWOT Analysis

12.2.7. Business Strategies

12.3. Fresenius Kabi

12.3.1. Company Details

12.3.2. Company Overview

12.3.3. Product Offerings

12.3.4. Key Developments

12.3.5. Financial Analysis

12.3.6. SWOT Analysis

12.3.7. Business Strategies

12.4. Smith Medical

12.4.1. Company Details

12.4.2. Company Overview

12.4.3. Product Offerings

12.4.4. Key Developments

12.4.5. Financial Analysis

12.4.6. SWOT Analysis

12.4.7. Business Strategies

12.5. B. Braun

12.5.1. Company Details

12.5.2. Company Overview

12.5.3. Product Offerings

12.5.4. Key Developments

12.5.5. Financial Analysis

12.5.6. SWOT Analysis

12.5.7. Business Strategies

12.6. Amsino International

12.6.1. Company Details

12.6.2. Company Overview

12.6.3. Product Offerings

12.6.4. Key Developments

12.6.5. Financial Analysis

12.6.6. SWOT Analysis

12.6.7. Business Strategies

12.7. Halyard Health

12.7.1. Company Details

12.7.2. Company Overview

12.7.3. Product Offerings

12.7.4. Key Developments

12.7.5. Financial Analysis

12.7.6. SWOT Analysis

12.7.7. Business Strategies

12.8. Terumo Corporation

12.8.1. Company Details

12.8.2. Company Overview

12.8.3. Product Offerings

12.8.4. Key Developments

12.8.5. Financial Analysis

12.8.6. SWOT Analysis

12.8.7. Business Strategies

12.9. Other industry participants

12.9.1. Company Details

12.9.2. Company Overview

12.9.3. Product Offerings

12.9.4. Key Developments

12.9.5. Financial Analysis

12.9.6. SWOT Analysis

12.9.7. Business Strategies

13. Key Findings: Home Infusion Therapy Market

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User.

 

 

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 163

    Backtrace:

    File: /var/www/html/ami/application/views/pages/reportpage.php
    Line: 163
    Function: _error_handler

    File: /var/www/html/ami/application/controllers/Report.php
    Line: 153
    Function: view

    File: /var/www/html/ami/index.php
    Line: 315
    Function: require_once